Australian IT Stock News

ASX:ELV
ASX:ELVMetals and Mining

Assessing Elevra Lithium (ASX:ELV) Valuation After Capital Raise And North American Lithium Expansion Update

Elevra Lithium (ASX:ELV) has moved back into focus after completing a fully underwritten A$275 million equity raise and releasing an updated Scoping Study for its North American Lithium expansion in Quebec. See our latest analysis for Elevra Lithium. These funding and project updates come after a sharp pullback, with a 7 day share price return of down 16.96% following a strong 90 day share price return of 44.8% and a very large 1 year total shareholder return. This suggests momentum has...
ASX:BXB
ASX:BXBCommercial Services

Brambles (ASX:BXB) Is Down 19.0% After US Bottlenecks Hit Guidance And A US$400m Buyback Launch

In May 2026, Brambles Limited (ASX:BXB) announced a new on-market share repurchase program of up to 134,664,225 shares (10% of its 1,346,642,250 shares on issue) for US$400 million, to be executed by June 30, 2027, aiming to improve capital efficiency and shareholder value. On the same day, Brambles cut its FY26 sales and earnings guidance due to US pallet repair capacity constraints, highlighting how labour shortages and higher quality standards in its subcontractor network are directly...
ASX:MQG
ASX:MQGCapital Markets

Macquarie Group (ASX:MQG) Valuation Check After Recent Share Price Momentum

Macquarie Group (ASX:MQG) has come into focus after recent share price moves, with the stock last closing at A$240.98. Investors are assessing this level in relation to the group’s diversified global earnings profile. See our latest analysis for Macquarie Group. Recent trading has been relatively upbeat, with a 1-day share price return of 1.87% and a 7-day share price return of 2.90% adding to a 90-day share price return of 9.74%. Over longer horizons, the 1-year total shareholder return of...
ASX:TNE
ASX:TNESoftware

Technology One (ASX:TNE) Net Margin Compression Tests Premium Growth Narrative

Technology One (ASX:TNE) has just posted its H1 2026 scorecard, with trailing twelve month revenue at A$631.2 million and basic EPS at A$0.433, set against a current share price of A$27.80. The company has seen revenue move from A$551.7 million with EPS of A$0.407 in the TTM period to H1 2025, to A$598.5 million and EPS of A$0.421 in the TTM to H2 2025, and then to A$631.2 million and EPS of A$0.433 in the latest TTM window. This gives investors a clear view of how the top and bottom lines...
ASX:ELD
ASX:ELDFood

Do Elders' (ASX:ELD) Steady EPS Mask Shifting Drivers Behind Its Profit Recovery?

Elders Limited recently reported past half-year results to 31 March 2026, with sales rising to A$1,767.68 million and net income to A$39.45 million, while basic earnings per share from continuing operations edged up to A$0.166. Despite higher sales and net income, overall basic earnings per share held steady at A$0.188, suggesting that profit growth was broadly matched by changes in the share base or one-off factors. We’ll now explore how Elders’ higher half-year sales and net income figures...
ASX:PDN
ASX:PDNOil and Gas

Paladin Energy (ASX:PDN) Is Down 16.3% After Returning To Quarterly Profitability Is The Bull Case Changed?

In May 2026, Paladin Energy Ltd reported its third-quarter and nine-month results to March 31, 2026, showing sales rising to US$70.7 million for the quarter and US$209.05 million for the nine months, with net income turning positive at US$0.779 million and US$1.65 million respectively after losses a year earlier. The move from loss to a small profit, with basic earnings per share improving from a loss of US$0.064 to earnings of US$0.002 for the quarter, highlights how even modest...
ASX:PME
ASX:PMEHealthcare Services

Pro Medicus ASX PME Valuation Check After New A$90 Million Beth Israel Lahey Health Cloud Imaging Deal

Pro Medicus (ASX:PME) has signed a seven year, A$90 million transaction-based deal with Beth Israel Lahey Health to deploy its Visage 7 cloud imaging platform across 14 US hospitals, underscoring its US healthcare expansion. See our latest analysis for Pro Medicus. The A$90 million Beth Israel Lahey Health deal lands at a time when the stock has climbed 2.8% over the past day but is down 15.6% on a 30 day share price return and 43.6% year to date. The three year total shareholder return of...
ASX:TYR
ASX:TYRDiversified Financial

ASX Penny Stocks With Market Caps Over A$20M To Watch

The Australian market is showing signs of potential recovery with futures indicating a possible one percent rise, despite a lackluster performance on Wall Street and fluctuating commodity prices. In the context of these market dynamics, penny stocks—often representing smaller or newer companies—present intriguing opportunities for investors. While the term "penny stocks" might seem outdated, these investments can offer significant growth potential when backed by strong financials and sound...
ASX:LYC
ASX:LYCMetals and Mining

Assessing Lynas Rare Earths (ASX:LYC) Valuation As Rare Earth Demand Draws Fresh Market Attention

Growing focus on rare earths and Lynas Recent commentary on rising global demand for rare earth elements in AI and advanced technologies has put Lynas Rare Earths (ASX:LYC) back in the spotlight for investors tracking this specialised mining space. See our latest analysis for Lynas Rare Earths. Lynas Rare Earths' share price has moved to A$18.93 after a 5.46% 1 day share price gain. The 30 day share price return is down 8.55%, and the year to date share price return of 54.91% sits alongside a...
ASX:NGI
ASX:NGICapital Markets

Asian Undervalued Small Caps With Insider Action In May 2026

In the midst of rising inflation and geopolitical uncertainties, Asian markets have been navigating a complex landscape, with small-cap stocks facing unique challenges and opportunities. As energy costs continue to climb, impacting inflation rates across the globe, investors are increasingly looking at small-cap companies in Asia for their potential resilience and growth prospects. Identifying promising small-cap stocks often involves examining insider activity as an indicator of confidence...
ASX:CBA
ASX:CBABanks

3 ASX Dividend Stocks Yielding Up To 4.2%

As the Australian market grapples with global uncertainties and fluctuating commodity prices, investors are increasingly seeking stability amidst the volatility. In such an environment, dividend stocks can offer a reliable income stream, making them an attractive option for those looking to balance their portfolios while navigating current market conditions.
ASX:REA
ASX:REAInteractive Media and Services

High Growth Tech Stocks in Australia for May 2026

As the Australian market grapples with a challenging start to the week, influenced by global economic jitters and a dip in US indices, investors are closely watching how these conditions might impact high-growth sectors. In such an environment, identifying tech stocks with robust innovation and adaptability can be crucial for navigating potential volatility and capitalizing on opportunities within Australia's dynamic tech landscape.
ASX:KSC
ASX:KSCLogistics

Brisbane Broncos And 2 Other ASX Penny Stocks To Consider

The Australian market is facing a challenging start to the week, with futures indicating a potential drop and recent global events contributing to an uncertain economic landscape. Despite these conditions, penny stocks remain an intriguing area for investors seeking growth opportunities at lower price points. Although the term may seem outdated, penny stocks often represent smaller or newer companies that can offer significant potential when backed by strong financials.
ASX:TBN
ASX:TBNOil and Gas

Tamboran Resources (ASX:TBN) Valuation Check After Recent Pullback And Longer Term Share Price Gains

Tamboran Resources (ASX:TBN) has drawn investor attention after its recent share price moves, with the stock down 3.9% over the past month and up 16.7% over the past 3 months. See our latest analysis for Tamboran Resources. The recent share price pullback, including a 2% decline in the last session to A$0.245 and a softer 1 month share price return of 3.92% down, comes against a stronger backdrop. The 3 month share price return of 16.67% and 1 year total shareholder return of 46.87% point to...